Following Diabetic Foot Ulcer Closure with BlueDrop® OneStep Foot Scanner™

This study is looking at how long diabetic foot ulcers (DFUs) stay closed after they've healed. If you participated in the CAMPX trial and your foot ulcer completely healed within 12 weeks, you might be able to join. The study uses a BlueDrop® OneStep Foot Scanner™ to take pictures and thermal images of your foot each morning, which are sent to a nurse. The main goal is to see how many people's ulcers stay closed for 52 weeks (one year). The study is currently unclear on its recruitment status and plans to enroll 50 people.

Study design
This is an observational study following participants from a previous trial. It plans to enroll 50 people.
What's involved
You would use a BlueDrop® OneStep Foot Scanner™ each morning. If you can't use the scale, you'll answer a questionnaire at 3, 6, 9, and 12 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 52 weeks (one year) to check for ulcer recurrence.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07360418

Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.

Recruiting
Not specifiedAges 18+Observational
Applied Biologics, LLC
~50 participants
Updated 2026-02-10 on ClinicalTrials.gov
What's tested:Blue Drop Foot Scanner

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Rate of Recurrence
Measured over 52 weeks
Diabetic Foot Ulcers (DFU)
Foot Ulcer Chronic
Ulcer
Diabetic Foot Ulcer
1 sites across 1 states
Michigan1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

The potential subject must have participated in the CAMPX trial and achieved complete closure by the 12-week endpoint.

Exclusion

The potential subject did not participate in the CAMPX trial.
The potential subject participated in the CAMPX trial and did not achieve complete closure.
  • Rate of Recurrence52 weeks

    To demonstrate durability of closure (rate of recurrence) of subjects with a closed diabetic foot ulcer during the CAMPX clinical trial comparing subjects treated with Single Layer Amniotic Membrane (SLAM) plus standard of care (SOC) to subjects treated with SOC alone.